ALX ONCOLOGY HOLDINGS INC: Coastlands Capital LP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Coastlands Capital LP disclosed a stake exceeding 5% in ALX Oncology Holdings Inc. via a Schedule 13G filing with the SEC (accession 0001104659-26-130295). The exact share count and percentage were not specified in the filing headline. The disclosure signals a significant new or expanded position by the institutional investor in the clinical-stage immuno-oncology company. Investors will watch for further detail on the size and intent of the stake, including whether it reflects passive or activist interest.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Coastlands Capital LP, ALX Oncology Holdings Inc